A new study from the UK has suggested that patients recently diagnosed with ocular hypertension or open angle glaucoma (OAG) could derive greater benefit from undergoing selective laser trabeculoplasty (SLT) rather than being treated with intraocular pressure-reducing eye drops.
New drug applications approved by US FDA as of 01 - 15 March 2019 which includes New Molecular Entities (NMEs) and new biologics. It
does not include Tentative Approvals. Supplemental approvals may have
occurred since the original approval date.
Long-term monotherapy with intravitreal aflibercept (IAI) is noninferior to IAI with rescue photodynamic therapy (IAI + rPDT) in terms of functional and anatomical improvements in patients with polyploidal choroidal vasculopathy (PCV), a new Singapore analysis of the PLANET* study has found.
drug applications approved by US FDA as of 16 - 28 February 2019 which
includes New Molecular Entities (NMEs) and new biologics. It does not
include Tentative Approvals. Supplemental approvals may have occurred
since the original approval date.
Intravitreal triamcinolone acetonide and the intravitreal dexamethasone implant demonstrate superior efficacy over periocular triamcinolone acetonide in the treatment of patients with uveitic macular oedema, with only modest elevations in intraocular pressure, according to the results of the POINT* trial.
Following a diet consisting of vegetables 200 g per day, fruit two times per day and fish two times per week is good advice for individuals at risk of age-related macular degeneration (AMD), as it yields a significant reduction in the risk of the eye disease, according to a recent study.
Diabetic retinopathy is a leading cause of blindness, making early detection of this condition crucial. Dr Yong Shao Onn from the Eagle Eye Centre at Mt Alvernia Hospital, Singapore, speaks to Roshini Claire Anthony on the diagnosis and treatment options.
Intravitreal injection of antivascular endothelial growth factor (anti-VEGF) therapy is a safe and effective treatment for neovascular age-related macular degeneration (AMD) over 2 years, the period for which data are available in this literature review.